Seer (SEER) Interest Coverage Ratio (2020 - 2026)
Seer (SEER) recorded quarterly Interest Coverage Ratio of 253.76 in Q1 2026, up 34.31% quarter-over-quarter from 386.33 in Q4 2025, and down 827.86% on a YoY basis from 34.86 in Q1 2025.
Seer (SEER) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Seer's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 253.76 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 827.86% year-over-year to 253.76; the TTM figure through Mar 2026 stood at 230.7 (down 1755.05% YoY), while the FY2025 annual figure was 77.22, down 77.26% from the prior year.
- Interest Coverage Ratio was 253.76 for Q1 2026 at Seer, up from 386.33 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 219.91 in Q4 2023 to a low of 5946.5 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 756.13 across 5 years, with a median of 297.77 in 2022.
- Biggest YoY gain for Interest Coverage Ratio was 164.34% in 2023; the steepest drop was 1951.85% in 2023.
- A 5-year view of Interest Coverage Ratio shows it stood at 341.77 in 2022, then jumped by 164.34% to 219.91 in 2023, then plunged by 496.69% to 872.34 in 2024, then surged by 55.71% to 386.33 in 2025, then jumped by 34.31% to 253.76 in 2026.
- The last three Interest Coverage Ratio figures came in at 253.76 (Q1 2026), 386.33 (Q4 2025), and 92.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | -253.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253.76 |
| Dec 31, 2025 | -386.33 |
| Sep 30, 2025 | -92.12 |
| Mar 31, 2025 | -27.35 |
| Dec 31, 2024 | -872.34 |
| Sep 30, 2024 | -108.59 |
| Jun 30, 2024 | -144.90 |
| Mar 31, 2024 | -345.10 |
| Dec 31, 2023 | 219.91 |
| Sep 30, 2023 | -2,584.50 |
| Jun 30, 2023 | -558.82 |
| Mar 31, 2023 | -118.81 |
| Dec 31, 2022 | -341.77 |
| Sep 30, 2022 | -125.96 |
| Jun 30, 2022 | -411.12 |
| Mar 31, 2022 | -5,946.50 |
| Dec 31, 2021 | -903.36 |
| Dec 31, 2020 | 1,449.00 |
| Sep 30, 2020 | -935.11 |